You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 5,485,827


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,485,827
Title: Methods and devices for treating plumonary vasoconstriction and asthma
Abstract:A method for treating or preventing bronchoconstriction or reversible pulmonary vasoconstriction in a mammal, which method includes causing the mammal to inhale a therapeutically-effective concentration of gaseous nitric oxide or a therapeutically-effective amount of a nitric oxide-releasing compound, and an inhaler device containing nitric oxide gas and/or a nitric oxide-releasing compound.
Inventor(s): Zapol; Warren M. (Concord, MA), Frostell; Claes (Danderyd, SE)
Assignee: The General Hospital Corporation (Boston, MA)
Application Number:08/384,792
Patent Claim Types:
see list of patent claims
Use; Delivery; Device; Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 5,485,827: A Detailed Analysis

Introduction

United States Patent 5,485,827, granted on January 23, 1996, is an example of a patent that has been subject to various analyses and interpretations within the patent landscape. To provide a comprehensive understanding, this article will delve into the key aspects of the patent, including its scope, claims, and the broader patent landscape.

Background of the Patent

Patent 5,485,827 was issued for an invention related to a specific technological advancement. While the exact details of this patent are not provided here, understanding the general context of patents from the 1990s is crucial. During this period, technological innovations were rapidly evolving, and patents played a critical role in protecting intellectual property.

Scope of the Patent

The scope of a patent is defined by its claims, which outline the specific features and limitations of the invention. For any patent, including 5,485,827, the scope is determined by:

  • Claim Language: The precise wording of the claims is critical. Each claim must be clear, concise, and define the invention without ambiguity[2].
  • Claim Types: Patents can include various types of claims, such as independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[3].

Claims Analysis

Independent Claims

Independent claims in a patent like 5,485,827 are the broadest claims and define the core of the invention. These claims must be novel, non-obvious, and useful to be patentable. For example, if the patent involves a new method or apparatus, the independent claims would describe the essential elements of this method or apparatus.

Dependent Claims

Dependent claims narrow down the scope of the independent claims by adding additional limitations. These claims are often used to provide further detail and to protect specific embodiments of the invention.

Claim Construction

The construction of claims is a legal process that determines the meaning and scope of the claims. This process is crucial in patent litigation and is guided by the patent's specification, drawings, and the prosecution history[2].

Patent Eligibility Criteria

In recent years, the USPTO has refined the criteria for determining patent eligibility, especially for AI-related inventions. While Patent 5,485,827 predates these updates, understanding these criteria is essential for contemporary patent practitioners:

  • Abstract Ideas: Claims that merely involve abstract ideas are not patent-eligible unless they are integrated into a practical application that provides concrete benefits[1].
  • Practical Applications: Highlighting real-world applications of the claimed method or system can bolster the argument for patent eligibility. For instance, specifying how an abstract idea is used in a real-time system to enhance functionality can make the claim patent-eligible[1].

Patent Landscape

The patent landscape surrounding 5,485,827 includes several key aspects:

Prior Art

Prior art refers to the existing body of knowledge in the field of the invention. For any patent, including 5,485,827, the prior art is crucial in determining novelty and non-obviousness. The USPTO and other patent offices use various tools, such as the Common Citation Document (CCD), to consolidate prior art citations from multiple offices[4].

Patent Families

Patent families are groups of related patent applications filed in different jurisdictions. Understanding the patent family of 5,485,827 can provide insights into the global protection strategy of the inventors. Tools like the Global Dossier service offered by the USPTO facilitate the analysis of patent families across different IP offices[4].

Inventorship

Determining the true and only inventors is a critical aspect of patent law. For patents like 5,485,827, ensuring that all contributors who conceived the idea and reduced it to practice are listed as inventors is essential. Joint inventorship occurs when multiple individuals collaborate on an invention, and each contributor must have made a significant and inventive contribution to the subject matter of the patent claims[2].

Search and Analysis Tools

Several tools are available for searching and analyzing patents:

  • USPTO Public Search Facility: This facility provides access to patent and trademark information in various formats, including online, microfilm, and print[4].
  • Patent Claims Research Dataset: This dataset contains detailed information on claims from U.S. patents and applications, which can be used to analyze claim structures and trends[3].

Real-World Applications and Practical Utility

To ensure patent eligibility, it is crucial to demonstrate how the claimed method or system provides practical utility and solves specific problems in the relevant field. For example, in the context of AI-related inventions, specifying how an abstract idea is applied in a real-time system to enhance functionality, such as improving the accuracy of speech recognition systems, can make the claim patent-eligible[1].

Key Takeaways

  • Clear Claim Language: The claims of a patent must be clear and concise to define the invention without ambiguity.
  • Practical Applications: Highlighting real-world applications of the claimed method or system is essential for patent eligibility.
  • Prior Art and Patent Families: Understanding prior art and patent families is crucial for determining novelty and non-obviousness.
  • Inventorship: Ensuring that all significant contributors are listed as inventors is vital for maintaining the enforceability of the patent.
  • Search and Analysis Tools: Utilizing tools like the USPTO Public Search Facility and the Patent Claims Research Dataset can aid in comprehensive patent analysis.

FAQs

Q: What is the importance of clear claim language in a patent?

A: Clear claim language is essential to define the invention without ambiguity, ensuring that the scope of the patent is well-understood and enforceable.

Q: How does the USPTO determine patent eligibility for AI-related inventions?

A: The USPTO determines patent eligibility by ensuring that AI-related claims integrate abstract ideas into practical applications that provide concrete benefits, as outlined in the 2024 USPTO guidance update[1].

Q: What is the role of prior art in patent analysis?

A: Prior art is crucial in determining the novelty and non-obviousness of an invention. It helps in identifying existing knowledge in the field and ensures that the patent claims are unique and innovative.

Q: How can one determine the true and only inventors for a patent?

A: Determining the true and only inventors involves identifying individuals who conceived the idea and reduced it to practice. Joint inventorship requires significant and inventive contributions to the subject matter of the patent claims[2].

Q: What tools are available for searching and analyzing patents?

A: Tools such as the USPTO Public Search Facility, Patent Claims Research Dataset, and Global Dossier service are available for comprehensive patent search and analysis[3][4].

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. Determining Inventorship for US Patent Applications - Oregon State University
  3. Patent Claims Research Dataset - USPTO
  4. Search for patents - USPTO - USPTO

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,485,827

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 5,485,827

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0560928 ⤷  Subscribe CA 2002 00002 Denmark ⤷  Subscribe
European Patent Office 0560928 ⤷  Subscribe SPC/GB02/009 United Kingdom ⤷  Subscribe
European Patent Office 0560928 ⤷  Subscribe 2002C/003 Belgium ⤷  Subscribe
European Patent Office 0786264 ⤷  Subscribe CA 2008 00019 Denmark ⤷  Subscribe
European Patent Office 0786264 ⤷  Subscribe 91423 Luxembourg ⤷  Subscribe
European Patent Office 0786264 ⤷  Subscribe SPC/GB08/019 United Kingdom ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.